Journal: The Open Cardiovascular Medicine Journal

Author(s): Carolina Baraldi Araujo Restini, Leticia Gonçalves

808253922d3a104fbf37e2cbbe9d8fd4440f9d715586e2a4d2pimgpsh_fullsize_distr

Abstract:

Increased number of patients affected by metabolic syndrome (MS) has prompted the necessity of better understanding what is involved in such syndrome. Nevertheless, the establishment of promising therapies depends on the knowledge about the interaction of molecules within MS. In such context, Nitric Oxide (NO) emerges from a bulk of works relating its roles on aspects of MS, including cardiovascular diseases, their symptoms and comorbidities, which are thought to be triggered by similar sources. NO, nitric oxide synthase and enzymatic chains are keys for those disease and symptoms processes. NO has been separately described as part of hypertensive, ischemic and pain signaling. Although there are similar pathways likely shared for generating cardiovascular symptoms such angina, they are barely associated to NO in literature. The present review aims to clarify the patterns of NO alteration in metabolic syndrome directly concerned to cardiovascular symptoms, especially angina.

To access this article, please visit: https://benthamopen.com/ABSTRACT/TOCMJ-11-33

Advertisements